Physicians Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
400
+15
| +4% | +$7.88K | 0.06% | 107 |
|
|
2025
Q1 | $244K | Hold |
385
| – | – | 0.08% | 99 |
|
|
2024
Q4 | $274K | Hold |
385
| – | – | 0.08% | 94 |
|
|
2024
Q3 | $405K | Sell |
385
-10
| -3% | -$10.5K | 0.13% | 86 |
|
|
2024
Q2 | $415K | Hold |
395
| – | – | 0.14% | 88 |
|
|
2024
Q1 | $380K | Hold |
395
| – | – | 0.13% | 88 |
|
|
2023
Q4 | $347K | Hold |
395
| – | – | 0.13% | 88 |
|
|
2023
Q3 | $325K | Hold |
395
| – | – | 0.13% | 91 |
|
|
2023
Q2 | $284K | Hold |
395
| – | – | 0.11% | 98 |
|
|
2023
Q1 | $325K | Hold |
395
| – | – | 0.14% | 92 |
|
|
2022
Q4 | $285K | Hold |
395
| – | – | 0.13% | 98 |
|
|
2022
Q3 | $272K | Hold |
395
| – | – | 0.13% | 94 |
|
|
2022
Q2 | $233K | Hold |
395
| – | – | 0.1% | 105 |
|
|
2022
Q1 | $276K | Buy |
395
+40
| +11% | +$27.9K | 0.11% | 106 |
|
|
2021
Q4 | $224K | Hold |
355
| – | – | 0.08% | 113 |
|
|
2021
Q3 | $215K | Buy |
+355
| New | +$215K | 0.09% | 114 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$41K | – | 224 |
|
|
2016
Q4 | $41K | Buy |
+100
| New | +$41K | 0.03% | 170 |
|
|
2016
Q3 | – | Sell |
-100
| Closed | -$35K | – | 309 |
|
|
2016
Q2 | $35K | Hold |
100
| – | – | 0.03% | 175 |
|
|
2016
Q1 | $36K | Hold |
100
| – | – | 0.03% | 168 |
|
|
2015
Q4 | $54K | Buy |
+100
| New | +$54K | 0.05% | 162 |
|